MONTREAL, April 15, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ("Theratechnologies" or the "Company") (TSX:TH) (NASDAQ:THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that the Company has mailed its 2024 management proxy circular to shareholders in connection with its virtual annual meeting of shareholders to be held on May 9, 2024, at 10:00 a.m. ET.
Shareholders are encouraged to vote their shares for the proposals contained in the circular and to attend the annual meeting, which can be accessed through the following link: https://meetnow.global/M7MFS6Y.
At the meeting, shareholders will be asked to vote for the following individuals as directors of the Company for the ensuing year:
- Joseph Arena;